European Patent Office

T 0228/23 (Stable compositions containing Sitagliptin / GALENICUM) of 24.09.2024

European Case Law Identifier
ECLI:EP:BA:2024:T022823.20240924
Date of decision
24 September 2024
Case number
T 0228/23
Petition for review of
-
Application number
15702266.6
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
Abstract on Article 056 EPC
Application title
STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING SITAGLIPTIN IN THE FORM OF IMMEDIATE RELEASE TABLETS
Applicant name
Galenicum Health S.L.U.
Opponent name
ELKINGTON AND FIFE LLP
Hoffmann Eitle Patent- und Rechtsanwälte
Partnerschaftsgesellschaft mbB
Mullen, Lee
Dentons UK and Middle East LLP
Laboratorios Liconsa, S.A.
Dentons Patent Solutions GmbH
Cooke, Richard
Board
3.3.07
Headnote
-
Relevant legal provisions
European Patent Convention Art 108European Patent Convention Art 54European Patent Convention Art 56European Patent Convention R 101(1)European Patent Convention R 99(2)Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Keywords
Admissibility of appeal - missing statement of grounds
Late-filed evidence - admitted (yes)
Late-filed submissions - admitted (no)
Novelty - main request (yes)
Inventive step - auxiliary requests 1 to 7 (no)
Catchword
-
Citing cases
-

Order

For these reasons it is decided that:

The decision under appeal is set aside.

The patent is revoked.